TrademarkDir
LYPTIMZ
LIVE

Serial Number

79296572

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 3, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LYPTIMZ Trademark

Serial Number: 79296572 • Registration: 6375328

LYPTIMZ is a trademark filed by Novartis AG on September 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

September 3, 2020

Registration Date

June 8, 2021

Published for Opposition

March 23, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 8, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 29, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 29, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 8, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 8, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 22, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
REFUSAL PROCESSED BY IB
Jan 24, 2021 RFNT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2021 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 5, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 5, 2021 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 16, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 16, 2020 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 16, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 15, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 31, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 26, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR

Related Trademarks

More from this Owner

NOVARTIS RLT NOW logo

NOVARTIS RLT NOW

NOVARTIS RLT NOW

NOVARTIS RLT NOW

TIVELGO

TIVELGO

KUNELMI

KUNELMI

Trademark logo

Serial #99735720

NOVARTIS NOVARTIS logo

NOVARTIS NOVARTIS